N. Wutte

发表

Spiritual well‐being and coping in scleroderma, lupus erythematosus, and melanoma

E. Aberer, H. Unterrainer, R. Fink‐Puches, 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Spirituality and mood pathology in severe skin conditions: a prospective observational study

E. Aberer, H. Unterrainer, R. Fink‐Puches, 2016, Archives of Dermatological Research.

European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

A. Gabrielli, L. Rudnicka, P. Wolf, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

CXCL 13 Chemokine as a diagnostic marker for Lyme Neuroborreliosis

A. Berghold, G. Kleinert, E. Aberer, 2009 .

Changes in pulmonary exercise haemodynamics in scleroderma: a 4-year prospective study

W. Graninger, M. Brodmann, H. Olschewski, 2017, European Respiratory Journal.

CXCL13 and B‐cell activating factor as putative biomarkers in systemic sclerosis

A. Berghold, W. Aberer, E. Aberer, 2013, The British journal of dermatology.

The influence of religious/spiritual well‐being on quality of life in dermatological disease

E. Aberer, H. Unterrainer, R. Fink‐Puches, 2016, The British journal of dermatology.

Cyclosporine Reduces Sclerosis in Morphea: A Retrospective Study in 12 Patients and a Literature Review

E. Aberer, G. Bali, J. Frühauf, 2016, Dermatology.

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

A. Gabrielli, L. Rudnicka, P. Wolf, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Atrophosclerodermic Manifestations of Lyme Borreliosis

E. Aberer, N. Wutte, 2016 .

Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses

E. Aberer, A. Avian, A. Bretterklieber, 2014, BMC Research Notes.

Toxocarosis and putative DRESS syndrome in an oncological patient: a case report

W. Aberer, H. Auer, M. Hoenigl, 2014, Wiener klinische Wochenschrift.

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: Comparison of two ELISAs, immunoblot and CXCL13 testing

F. Fazekas, J. Archelos, E. Aberer, 2014, Journal of the Neurological Sciences.

CXCL13 chemokine in pediatric and adult neuroborreliosis

A. Berghold, G. Kleinert, E. Aberer, 2011, Acta neurologica Scandinavica.

Clinical-Pathological Conference Series from the Medical University of Graz

G. Krejs, H. Mischinger, E. Fabian, 2018, Wiener klinische Wochenschrift.

Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature

E. Aberer, M. Klebes, N. Wutte, 2015, Dermatology.

CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study

A. Berghold, G. Schwantzer, M. Stradner, 2018, Archives of Dermatological Research.

Frontal hair loss and facial skin changes

N. Wutte, L. El-Shabrawi-Caelen, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Serum CXCL13 chemokine is not a marker for active Lyme borreliosis.

A. Berghold, E. Aberer, N. Wutte, 2011, Acta dermato-venereologica.

Specificity of conventional and Ves v 5-spiked venom decreases with increasing total IgE.

G. Sturm, W. Aberer, N. Wutte, 2014, Journal of Allergy and Clinical Immunology.

Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

M. Worm, G. Girolomoni, M. Sticherling, 2013, Autoimmunity reviews.

Within European margins

L. Cerroni, V. Fingerle, E. Aberer, 2011, The Lancet.

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

A. Gabrielli, L. Rudnicka, P. Wolf, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

R. Knobler, M. Olszewska, J. Seneschal, 2024, Journal of the European Academy of Dermatology and Venereology.

European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

A. Gabrielli, L. Rudnicka, P. Wolf, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.